A detailed history of West Family Investments, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, West Family Investments, Inc. holds 1,190 shares of REGN stock, worth $835,201. This represents 0.44% of its overall portfolio holdings.

Number of Shares
1,190
Previous 1,185 0.42%
Holding current value
$835,201
Previous $1.25 Million 0.4%
% of portfolio
0.44%
Previous 0.39%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$1024.09 - $1201.76 $5,120 - $6,008
5 Added 0.42%
1,190 $1.25 Million
Q2 2024

Aug 05, 2024

BUY
$883.2 - $1071.19 $1,766 - $2,142
2 Added 0.17%
1,185 $1.25 Million
Q1 2024

May 13, 2024

BUY
$902.69 - $993.35 $41,523 - $45,694
46 Added 4.05%
1,183 $1.14 Million
Q3 2023

Nov 02, 2023

SELL
$692.45 - $844.37 $141,259 - $172,251
-204 Reduced 15.21%
1,137 $935,000
Q1 2023

May 03, 2023

SELL
$680.49 - $826.97 $20,414 - $24,809
-30 Reduced 2.19%
1,341 $1.1 Million
Q4 2022

Feb 08, 2023

SELL
$705.89 - $766.39 $139,766 - $151,745
-198 Reduced 12.62%
1,371 $989,000
Q3 2022

Nov 04, 2022

SELL
$573.97 - $724.32 $40,751 - $51,426
-71 Reduced 4.33%
1,569 $1.08 Million
Q2 2022

Aug 12, 2022

SELL
$548.35 - $738.84 $93,767 - $126,341
-171 Reduced 9.44%
1,640 $969,000
Q1 2022

May 13, 2022

SELL
$595.12 - $698.43 $10,117 - $11,873
-17 Reduced 0.93%
1,811 $1.26 Million
Q4 2021

Feb 07, 2022

SELL
$543.48 - $670.97 $110,869 - $136,877
-204 Reduced 10.04%
1,828 $1.15 Million
Q3 2021

Oct 25, 2021

BUY
$574.03 - $680.96 $130,878 - $155,258
228 Added 12.64%
2,032 $1.23 Million
Q2 2021

Aug 12, 2021

BUY
$472.8 - $558.54 $852,931 - $1.01 Million
1,804 New
1,804 $1.01 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track West Family Investments, Inc. Portfolio

Follow West Family Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Family Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Family Investments, Inc. with notifications on news.